nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—kidney cancer—Dexamethasone—ankylosing spondylitis	0.178	0.29	CpDpCtD
Omeprazole—kidney cancer—Betamethasone—ankylosing spondylitis	0.178	0.29	CpDpCtD
Omeprazole—prostate cancer—Dexamethasone—ankylosing spondylitis	0.129	0.21	CpDpCtD
Omeprazole—prostate cancer—Betamethasone—ankylosing spondylitis	0.129	0.21	CpDpCtD
Omeprazole—CYP11A1—Dexamethasone—ankylosing spondylitis	0.0568	0.178	CbGbCtD
Omeprazole—CYP1B1—Dexamethasone—ankylosing spondylitis	0.0326	0.102	CbGbCtD
Omeprazole—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0311	0.0974	CbGbCtD
Omeprazole—ABCC3—Methotrexate—ankylosing spondylitis	0.0303	0.0951	CbGbCtD
Omeprazole—ABCG2—Dexamethasone—ankylosing spondylitis	0.0155	0.0486	CbGbCtD
Omeprazole—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0148	0.0463	CbGbCtD
Omeprazole—CYP1A1—Dexamethasone—ankylosing spondylitis	0.0143	0.0449	CbGbCtD
Omeprazole—ABCG2—Methotrexate—ankylosing spondylitis	0.0125	0.0391	CbGbCtD
Omeprazole—CYP2C19—Prednisone—ankylosing spondylitis	0.0111	0.0348	CbGbCtD
Omeprazole—ABCB1—Betamethasone—ankylosing spondylitis	0.00962	0.0301	CbGbCtD
Omeprazole—ABCB1—Prednisolone—ankylosing spondylitis	0.00949	0.0297	CbGbCtD
Omeprazole—ABCB1—Prednisone—ankylosing spondylitis	0.00896	0.0281	CbGbCtD
Omeprazole—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.00886	0.0278	CbGbCtD
Omeprazole—CYP2C8—Dexamethasone—ankylosing spondylitis	0.00826	0.0259	CbGbCtD
Omeprazole—CYP2C19—Dexamethasone—ankylosing spondylitis	0.00693	0.0217	CbGbCtD
Omeprazole—CYP3A4—Triamcinolone—ankylosing spondylitis	0.00672	0.021	CbGbCtD
Omeprazole—CYP2C9—Dexamethasone—ankylosing spondylitis	0.00576	0.0181	CbGbCtD
Omeprazole—CYP3A4—Betamethasone—ankylosing spondylitis	0.00576	0.0181	CbGbCtD
Omeprazole—CYP3A4—Prednisolone—ankylosing spondylitis	0.00569	0.0178	CbGbCtD
Omeprazole—ABCB1—Dexamethasone—ankylosing spondylitis	0.00559	0.0175	CbGbCtD
Omeprazole—CYP3A4—Prednisone—ankylosing spondylitis	0.00537	0.0168	CbGbCtD
Omeprazole—CYP2D6—Dexamethasone—ankylosing spondylitis	0.00527	0.0165	CbGbCtD
Omeprazole—ABCB1—Methotrexate—ankylosing spondylitis	0.0045	0.0141	CbGbCtD
Omeprazole—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00335	0.0105	CbGbCtD
Omeprazole—Angioedema—Dexamethasone—ankylosing spondylitis	8.18e-05	0.00124	CcSEcCtD
Omeprazole—Angioedema—Betamethasone—ankylosing spondylitis	8.18e-05	0.00124	CcSEcCtD
Omeprazole—Stomatitis—Methotrexate—ankylosing spondylitis	8.13e-05	0.00123	CcSEcCtD
Omeprazole—Conjunctivitis—Methotrexate—ankylosing spondylitis	8.11e-05	0.00123	CcSEcCtD
Omeprazole—Confusional state—Methylprednisolone—ankylosing spondylitis	8.1e-05	0.00123	CcSEcCtD
Omeprazole—Immune system disorder—Prednisone—ankylosing spondylitis	8.09e-05	0.00123	CcSEcCtD
Omeprazole—Malaise—Betamethasone—ankylosing spondylitis	8.08e-05	0.00122	CcSEcCtD
Omeprazole—Malaise—Dexamethasone—ankylosing spondylitis	8.08e-05	0.00122	CcSEcCtD
Omeprazole—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	8.06e-05	0.00122	CcSEcCtD
Omeprazole—Vertigo—Betamethasone—ankylosing spondylitis	8.05e-05	0.00122	CcSEcCtD
Omeprazole—Vertigo—Dexamethasone—ankylosing spondylitis	8.05e-05	0.00122	CcSEcCtD
Omeprazole—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	8.04e-05	0.00122	CcSEcCtD
Omeprazole—Infection—Triamcinolone—ankylosing spondylitis	8e-05	0.00121	CcSEcCtD
Omeprazole—Infection—Methylprednisolone—ankylosing spondylitis	7.98e-05	0.00121	CcSEcCtD
Omeprazole—Haematuria—Methotrexate—ankylosing spondylitis	7.95e-05	0.0012	CcSEcCtD
Omeprazole—Shock—Triamcinolone—ankylosing spondylitis	7.92e-05	0.0012	CcSEcCtD
Omeprazole—Insomnia—Prednisolone—ankylosing spondylitis	7.92e-05	0.0012	CcSEcCtD
Omeprazole—Alopecia—Prednisone—ankylosing spondylitis	7.92e-05	0.0012	CcSEcCtD
Omeprazole—Shock—Methylprednisolone—ankylosing spondylitis	7.91e-05	0.0012	CcSEcCtD
Omeprazole—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	7.89e-05	0.00119	CcSEcCtD
Omeprazole—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	7.88e-05	0.00119	CcSEcCtD
Omeprazole—Epistaxis—Methotrexate—ankylosing spondylitis	7.87e-05	0.00119	CcSEcCtD
Omeprazole—Paraesthesia—Prednisolone—ankylosing spondylitis	7.87e-05	0.00119	CcSEcCtD
Omeprazole—Tachycardia—Triamcinolone—ankylosing spondylitis	7.86e-05	0.00119	CcSEcCtD
Omeprazole—Mental disorder—Prednisone—ankylosing spondylitis	7.85e-05	0.00119	CcSEcCtD
Omeprazole—Tachycardia—Methylprednisolone—ankylosing spondylitis	7.84e-05	0.00119	CcSEcCtD
Omeprazole—Skin disorder—Methylprednisolone—ankylosing spondylitis	7.81e-05	0.00118	CcSEcCtD
Omeprazole—Malnutrition—Prednisone—ankylosing spondylitis	7.8e-05	0.00118	CcSEcCtD
Omeprazole—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	7.79e-05	0.00118	CcSEcCtD
Omeprazole—Agranulocytosis—Methotrexate—ankylosing spondylitis	7.78e-05	0.00118	CcSEcCtD
Omeprazole—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	7.77e-05	0.00118	CcSEcCtD
Omeprazole—Hypertension—Dexamethasone—ankylosing spondylitis	7.73e-05	0.00117	CcSEcCtD
Omeprazole—Hypertension—Betamethasone—ankylosing spondylitis	7.73e-05	0.00117	CcSEcCtD
Omeprazole—Myalgia—Dexamethasone—ankylosing spondylitis	7.62e-05	0.00115	CcSEcCtD
Omeprazole—Myalgia—Betamethasone—ankylosing spondylitis	7.62e-05	0.00115	CcSEcCtD
Omeprazole—Anxiety—Dexamethasone—ankylosing spondylitis	7.6e-05	0.00115	CcSEcCtD
Omeprazole—Anxiety—Betamethasone—ankylosing spondylitis	7.6e-05	0.00115	CcSEcCtD
Omeprazole—Discomfort—Betamethasone—ankylosing spondylitis	7.53e-05	0.00114	CcSEcCtD
Omeprazole—Discomfort—Dexamethasone—ankylosing spondylitis	7.53e-05	0.00114	CcSEcCtD
Omeprazole—Pain—Prednisolone—ankylosing spondylitis	7.49e-05	0.00113	CcSEcCtD
Omeprazole—Hepatitis—Methotrexate—ankylosing spondylitis	7.49e-05	0.00113	CcSEcCtD
Omeprazole—Pharyngitis—Methotrexate—ankylosing spondylitis	7.43e-05	0.00113	CcSEcCtD
Omeprazole—Urinary tract disorder—Methotrexate—ankylosing spondylitis	7.39e-05	0.00112	CcSEcCtD
Omeprazole—Vision blurred—Prednisone—ankylosing spondylitis	7.35e-05	0.00111	CcSEcCtD
Omeprazole—Urethral disorder—Methotrexate—ankylosing spondylitis	7.34e-05	0.00111	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	7.34e-05	0.00111	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	7.32e-05	0.00111	CcSEcCtD
Omeprazole—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	7.31e-05	0.00111	CcSEcCtD
Omeprazole—Anaphylactic shock—Betamethasone—ankylosing spondylitis	7.31e-05	0.00111	CcSEcCtD
Omeprazole—Insomnia—Triamcinolone—ankylosing spondylitis	7.29e-05	0.0011	CcSEcCtD
Omeprazole—Insomnia—Methylprednisolone—ankylosing spondylitis	7.27e-05	0.0011	CcSEcCtD
Omeprazole—Infection—Dexamethasone—ankylosing spondylitis	7.26e-05	0.0011	CcSEcCtD
Omeprazole—Infection—Betamethasone—ankylosing spondylitis	7.26e-05	0.0011	CcSEcCtD
Omeprazole—Ill-defined disorder—Prednisone—ankylosing spondylitis	7.24e-05	0.0011	CcSEcCtD
Omeprazole—Paraesthesia—Triamcinolone—ankylosing spondylitis	7.23e-05	0.0011	CcSEcCtD
Omeprazole—Feeling abnormal—Prednisolone—ankylosing spondylitis	7.22e-05	0.00109	CcSEcCtD
Omeprazole—Paraesthesia—Methylprednisolone—ankylosing spondylitis	7.22e-05	0.00109	CcSEcCtD
Omeprazole—Visual impairment—Methotrexate—ankylosing spondylitis	7.22e-05	0.00109	CcSEcCtD
Omeprazole—Anaemia—Prednisone—ankylosing spondylitis	7.21e-05	0.00109	CcSEcCtD
Omeprazole—Shock—Dexamethasone—ankylosing spondylitis	7.19e-05	0.00109	CcSEcCtD
Omeprazole—Shock—Betamethasone—ankylosing spondylitis	7.19e-05	0.00109	CcSEcCtD
Omeprazole—Dyspnoea—Triamcinolone—ankylosing spondylitis	7.18e-05	0.00109	CcSEcCtD
Omeprazole—Nervous system disorder—Dexamethasone—ankylosing spondylitis	7.17e-05	0.00109	CcSEcCtD
Omeprazole—Nervous system disorder—Betamethasone—ankylosing spondylitis	7.17e-05	0.00109	CcSEcCtD
Omeprazole—Agitation—Prednisone—ankylosing spondylitis	7.17e-05	0.00109	CcSEcCtD
Omeprazole—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	7.16e-05	0.00108	CcSEcCtD
Omeprazole—Thrombocytopenia—Betamethasone—ankylosing spondylitis	7.16e-05	0.00108	CcSEcCtD
Omeprazole—Tachycardia—Betamethasone—ankylosing spondylitis	7.13e-05	0.00108	CcSEcCtD
Omeprazole—Tachycardia—Dexamethasone—ankylosing spondylitis	7.13e-05	0.00108	CcSEcCtD
Omeprazole—Angioedema—Prednisone—ankylosing spondylitis	7.13e-05	0.00108	CcSEcCtD
Omeprazole—Dyspepsia—Triamcinolone—ankylosing spondylitis	7.09e-05	0.00107	CcSEcCtD
Omeprazole—Erythema multiforme—Methotrexate—ankylosing spondylitis	7.08e-05	0.00107	CcSEcCtD
Omeprazole—Dyspepsia—Methylprednisolone—ankylosing spondylitis	7.07e-05	0.00107	CcSEcCtD
Omeprazole—Hyperhidrosis—Betamethasone—ankylosing spondylitis	7.07e-05	0.00107	CcSEcCtD
Omeprazole—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	7.07e-05	0.00107	CcSEcCtD
Omeprazole—Malaise—Prednisone—ankylosing spondylitis	7.03e-05	0.00106	CcSEcCtD
Omeprazole—Vertigo—Prednisone—ankylosing spondylitis	7.01e-05	0.00106	CcSEcCtD
Omeprazole—Eye disorder—Methotrexate—ankylosing spondylitis	7e-05	0.00106	CcSEcCtD
Omeprazole—Tinnitus—Methotrexate—ankylosing spondylitis	6.98e-05	0.00106	CcSEcCtD
Omeprazole—Anorexia—Dexamethasone—ankylosing spondylitis	6.97e-05	0.00105	CcSEcCtD
Omeprazole—Anorexia—Betamethasone—ankylosing spondylitis	6.97e-05	0.00105	CcSEcCtD
Omeprazole—Urticaria—Prednisolone—ankylosing spondylitis	6.96e-05	0.00105	CcSEcCtD
Omeprazole—Fatigue—Triamcinolone—ankylosing spondylitis	6.94e-05	0.00105	CcSEcCtD
Omeprazole—Fatigue—Methylprednisolone—ankylosing spondylitis	6.93e-05	0.00105	CcSEcCtD
Omeprazole—Pain—Triamcinolone—ankylosing spondylitis	6.89e-05	0.00104	CcSEcCtD
Omeprazole—Immune system disorder—Methotrexate—ankylosing spondylitis	6.76e-05	0.00102	CcSEcCtD
Omeprazole—Mediastinal disorder—Methotrexate—ankylosing spondylitis	6.75e-05	0.00102	CcSEcCtD
Omeprazole—Hypertension—Prednisone—ankylosing spondylitis	6.73e-05	0.00102	CcSEcCtD
Omeprazole—Chills—Methotrexate—ankylosing spondylitis	6.72e-05	0.00102	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	6.66e-05	0.00101	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	6.66e-05	0.00101	CcSEcCtD
Omeprazole—Arthralgia—Prednisone—ankylosing spondylitis	6.64e-05	0.00101	CcSEcCtD
Omeprazole—Myalgia—Prednisone—ankylosing spondylitis	6.64e-05	0.00101	CcSEcCtD
Omeprazole—Feeling abnormal—Triamcinolone—ankylosing spondylitis	6.64e-05	0.001	CcSEcCtD
Omeprazole—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	6.62e-05	0.001	CcSEcCtD
Omeprazole—Anxiety—Prednisone—ankylosing spondylitis	6.62e-05	0.001	CcSEcCtD
Omeprazole—Alopecia—Methotrexate—ankylosing spondylitis	6.62e-05	0.001	CcSEcCtD
Omeprazole—Insomnia—Dexamethasone—ankylosing spondylitis	6.61e-05	0.001	CcSEcCtD
Omeprazole—Insomnia—Betamethasone—ankylosing spondylitis	6.61e-05	0.001	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	6.59e-05	0.000998	CcSEcCtD
Omeprazole—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	6.57e-05	0.000995	CcSEcCtD
Omeprazole—Paraesthesia—Dexamethasone—ankylosing spondylitis	6.56e-05	0.000994	CcSEcCtD
Omeprazole—Paraesthesia—Betamethasone—ankylosing spondylitis	6.56e-05	0.000994	CcSEcCtD
Omeprazole—Discomfort—Prednisone—ankylosing spondylitis	6.56e-05	0.000993	CcSEcCtD
Omeprazole—Mental disorder—Methotrexate—ankylosing spondylitis	6.56e-05	0.000993	CcSEcCtD
Omeprazole—Malnutrition—Methotrexate—ankylosing spondylitis	6.52e-05	0.000987	CcSEcCtD
Omeprazole—Hypersensitivity—Prednisolone—ankylosing spondylitis	6.45e-05	0.000977	CcSEcCtD
Omeprazole—Dyspepsia—Dexamethasone—ankylosing spondylitis	6.43e-05	0.000974	CcSEcCtD
Omeprazole—Dyspepsia—Betamethasone—ankylosing spondylitis	6.43e-05	0.000974	CcSEcCtD
Omeprazole—Urticaria—Triamcinolone—ankylosing spondylitis	6.4e-05	0.000969	CcSEcCtD
Omeprazole—Urticaria—Methylprednisolone—ankylosing spondylitis	6.38e-05	0.000967	CcSEcCtD
Omeprazole—Dysgeusia—Methotrexate—ankylosing spondylitis	6.38e-05	0.000966	CcSEcCtD
Omeprazole—Body temperature increased—Triamcinolone—ankylosing spondylitis	6.37e-05	0.000964	CcSEcCtD
Omeprazole—Anaphylactic shock—Prednisone—ankylosing spondylitis	6.36e-05	0.000964	CcSEcCtD
Omeprazole—Abdominal pain—Methylprednisolone—ankylosing spondylitis	6.35e-05	0.000962	CcSEcCtD
Omeprazole—Decreased appetite—Dexamethasone—ankylosing spondylitis	6.35e-05	0.000962	CcSEcCtD
Omeprazole—Decreased appetite—Betamethasone—ankylosing spondylitis	6.35e-05	0.000962	CcSEcCtD
Omeprazole—Infection—Prednisone—ankylosing spondylitis	6.32e-05	0.000957	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	6.31e-05	0.000955	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	6.31e-05	0.000955	CcSEcCtD
Omeprazole—Back pain—Methotrexate—ankylosing spondylitis	6.3e-05	0.000954	CcSEcCtD
Omeprazole—Fatigue—Dexamethasone—ankylosing spondylitis	6.3e-05	0.000954	CcSEcCtD
Omeprazole—Fatigue—Betamethasone—ankylosing spondylitis	6.3e-05	0.000954	CcSEcCtD
Omeprazole—Shock—Prednisone—ankylosing spondylitis	6.26e-05	0.000948	CcSEcCtD
Omeprazole—Pain—Betamethasone—ankylosing spondylitis	6.25e-05	0.000946	CcSEcCtD
Omeprazole—Pain—Dexamethasone—ankylosing spondylitis	6.25e-05	0.000946	CcSEcCtD
Omeprazole—Nervous system disorder—Prednisone—ankylosing spondylitis	6.24e-05	0.000945	CcSEcCtD
Omeprazole—Tachycardia—Prednisone—ankylosing spondylitis	6.21e-05	0.00094	CcSEcCtD
Omeprazole—Skin disorder—Prednisone—ankylosing spondylitis	6.18e-05	0.000936	CcSEcCtD
Omeprazole—Hyperhidrosis—Prednisone—ankylosing spondylitis	6.15e-05	0.000932	CcSEcCtD
Omeprazole—Vision blurred—Methotrexate—ankylosing spondylitis	6.14e-05	0.00093	CcSEcCtD
Omeprazole—Anorexia—Prednisone—ankylosing spondylitis	6.07e-05	0.000919	CcSEcCtD
Omeprazole—Ill-defined disorder—Methotrexate—ankylosing spondylitis	6.05e-05	0.000916	CcSEcCtD
Omeprazole—Anaemia—Methotrexate—ankylosing spondylitis	6.02e-05	0.000912	CcSEcCtD
Omeprazole—Feeling abnormal—Dexamethasone—ankylosing spondylitis	6.02e-05	0.000912	CcSEcCtD
Omeprazole—Feeling abnormal—Betamethasone—ankylosing spondylitis	6.02e-05	0.000912	CcSEcCtD
Omeprazole—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	5.98e-05	0.000905	CcSEcCtD
Omeprazole—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	5.98e-05	0.000905	CcSEcCtD
Omeprazole—Hypersensitivity—Triamcinolone—ankylosing spondylitis	5.93e-05	0.000898	CcSEcCtD
Omeprazole—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	5.92e-05	0.000896	CcSEcCtD
Omeprazole—Malaise—Methotrexate—ankylosing spondylitis	5.88e-05	0.00089	CcSEcCtD
Omeprazole—Vertigo—Methotrexate—ankylosing spondylitis	5.86e-05	0.000887	CcSEcCtD
Omeprazole—Leukopenia—Methotrexate—ankylosing spondylitis	5.83e-05	0.000883	CcSEcCtD
Omeprazole—Urticaria—Dexamethasone—ankylosing spondylitis	5.81e-05	0.000879	CcSEcCtD
Omeprazole—Urticaria—Betamethasone—ankylosing spondylitis	5.81e-05	0.000879	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	5.8e-05	0.000878	CcSEcCtD
Omeprazole—Dizziness—Prednisolone—ankylosing spondylitis	5.79e-05	0.000877	CcSEcCtD
Omeprazole—Asthenia—Triamcinolone—ankylosing spondylitis	5.78e-05	0.000875	CcSEcCtD
Omeprazole—Abdominal pain—Dexamethasone—ankylosing spondylitis	5.78e-05	0.000875	CcSEcCtD
Omeprazole—Body temperature increased—Dexamethasone—ankylosing spondylitis	5.78e-05	0.000875	CcSEcCtD
Omeprazole—Abdominal pain—Betamethasone—ankylosing spondylitis	5.78e-05	0.000875	CcSEcCtD
Omeprazole—Body temperature increased—Betamethasone—ankylosing spondylitis	5.78e-05	0.000875	CcSEcCtD
Omeprazole—Asthenia—Methylprednisolone—ankylosing spondylitis	5.77e-05	0.000873	CcSEcCtD
Omeprazole—Insomnia—Prednisone—ankylosing spondylitis	5.76e-05	0.000872	CcSEcCtD
Omeprazole—Paraesthesia—Prednisone—ankylosing spondylitis	5.72e-05	0.000865	CcSEcCtD
Omeprazole—Pruritus—Triamcinolone—ankylosing spondylitis	5.7e-05	0.000863	CcSEcCtD
Omeprazole—Cough—Methotrexate—ankylosing spondylitis	5.69e-05	0.000861	CcSEcCtD
Omeprazole—Pruritus—Methylprednisolone—ankylosing spondylitis	5.69e-05	0.000861	CcSEcCtD
Omeprazole—Dyspepsia—Prednisone—ankylosing spondylitis	5.6e-05	0.000848	CcSEcCtD
Omeprazole—Chest pain—Methotrexate—ankylosing spondylitis	5.55e-05	0.00084	CcSEcCtD
Omeprazole—Myalgia—Methotrexate—ankylosing spondylitis	5.55e-05	0.00084	CcSEcCtD
Omeprazole—Arthralgia—Methotrexate—ankylosing spondylitis	5.55e-05	0.00084	CcSEcCtD
Omeprazole—Decreased appetite—Prednisone—ankylosing spondylitis	5.53e-05	0.000838	CcSEcCtD
Omeprazole—Rash—Prednisolone—ankylosing spondylitis	5.52e-05	0.000836	CcSEcCtD
Omeprazole—Dermatitis—Prednisolone—ankylosing spondylitis	5.52e-05	0.000835	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	5.51e-05	0.000834	CcSEcCtD
Omeprazole—Diarrhoea—Methylprednisolone—ankylosing spondylitis	5.5e-05	0.000833	CcSEcCtD
Omeprazole—Fatigue—Prednisone—ankylosing spondylitis	5.49e-05	0.000831	CcSEcCtD
Omeprazole—Headache—Prednisolone—ankylosing spondylitis	5.49e-05	0.000831	CcSEcCtD
Omeprazole—Discomfort—Methotrexate—ankylosing spondylitis	5.48e-05	0.00083	CcSEcCtD
Omeprazole—Constipation—Prednisone—ankylosing spondylitis	5.44e-05	0.000824	CcSEcCtD
Omeprazole—Confusional state—Methotrexate—ankylosing spondylitis	5.36e-05	0.000812	CcSEcCtD
Omeprazole—Dizziness—Triamcinolone—ankylosing spondylitis	5.33e-05	0.000806	CcSEcCtD
Omeprazole—Anaphylactic shock—Methotrexate—ankylosing spondylitis	5.32e-05	0.000805	CcSEcCtD
Omeprazole—Dizziness—Methylprednisolone—ankylosing spondylitis	5.31e-05	0.000805	CcSEcCtD
Omeprazole—Infection—Methotrexate—ankylosing spondylitis	5.28e-05	0.0008	CcSEcCtD
Omeprazole—Feeling abnormal—Prednisone—ankylosing spondylitis	5.25e-05	0.000794	CcSEcCtD
Omeprazole—Asthenia—Betamethasone—ankylosing spondylitis	5.24e-05	0.000794	CcSEcCtD
Omeprazole—Asthenia—Dexamethasone—ankylosing spondylitis	5.24e-05	0.000794	CcSEcCtD
Omeprazole—Nervous system disorder—Methotrexate—ankylosing spondylitis	5.22e-05	0.00079	CcSEcCtD
Omeprazole—Thrombocytopenia—Methotrexate—ankylosing spondylitis	5.21e-05	0.000789	CcSEcCtD
Omeprazole—Gastrointestinal pain—Prednisone—ankylosing spondylitis	5.2e-05	0.000788	CcSEcCtD
Omeprazole—Nausea—Prednisolone—ankylosing spondylitis	5.2e-05	0.000788	CcSEcCtD
Omeprazole—Pruritus—Betamethasone—ankylosing spondylitis	5.17e-05	0.000783	CcSEcCtD
Omeprazole—Pruritus—Dexamethasone—ankylosing spondylitis	5.17e-05	0.000783	CcSEcCtD
Omeprazole—Skin disorder—Methotrexate—ankylosing spondylitis	5.17e-05	0.000782	CcSEcCtD
Omeprazole—Hyperhidrosis—Methotrexate—ankylosing spondylitis	5.14e-05	0.000779	CcSEcCtD
Omeprazole—Vomiting—Triamcinolone—ankylosing spondylitis	5.12e-05	0.000775	CcSEcCtD
Omeprazole—Vomiting—Methylprednisolone—ankylosing spondylitis	5.11e-05	0.000774	CcSEcCtD
Omeprazole—Rash—Triamcinolone—ankylosing spondylitis	5.08e-05	0.000769	CcSEcCtD
Omeprazole—Dermatitis—Triamcinolone—ankylosing spondylitis	5.07e-05	0.000768	CcSEcCtD
Omeprazole—Anorexia—Methotrexate—ankylosing spondylitis	5.07e-05	0.000768	CcSEcCtD
Omeprazole—Rash—Methylprednisolone—ankylosing spondylitis	5.07e-05	0.000767	CcSEcCtD
Omeprazole—Dermatitis—Methylprednisolone—ankylosing spondylitis	5.06e-05	0.000766	CcSEcCtD
Omeprazole—Urticaria—Prednisone—ankylosing spondylitis	5.06e-05	0.000766	CcSEcCtD
Omeprazole—Headache—Triamcinolone—ankylosing spondylitis	5.05e-05	0.000764	CcSEcCtD
Omeprazole—Headache—Methylprednisolone—ankylosing spondylitis	5.03e-05	0.000762	CcSEcCtD
Omeprazole—Abdominal pain—Prednisone—ankylosing spondylitis	5.03e-05	0.000762	CcSEcCtD
Omeprazole—Body temperature increased—Prednisone—ankylosing spondylitis	5.03e-05	0.000762	CcSEcCtD
Omeprazole—Diarrhoea—Betamethasone—ankylosing spondylitis	5e-05	0.000757	CcSEcCtD
Omeprazole—Diarrhoea—Dexamethasone—ankylosing spondylitis	5e-05	0.000757	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	4.85e-05	0.000734	CcSEcCtD
Omeprazole—Dizziness—Betamethasone—ankylosing spondylitis	4.83e-05	0.000732	CcSEcCtD
Omeprazole—Dizziness—Dexamethasone—ankylosing spondylitis	4.83e-05	0.000732	CcSEcCtD
Omeprazole—Insomnia—Methotrexate—ankylosing spondylitis	4.81e-05	0.000728	CcSEcCtD
Omeprazole—Nausea—Triamcinolone—ankylosing spondylitis	4.78e-05	0.000724	CcSEcCtD
Omeprazole—Paraesthesia—Methotrexate—ankylosing spondylitis	4.78e-05	0.000723	CcSEcCtD
Omeprazole—Nausea—Methylprednisolone—ankylosing spondylitis	4.77e-05	0.000723	CcSEcCtD
Omeprazole—Dyspnoea—Methotrexate—ankylosing spondylitis	4.74e-05	0.000718	CcSEcCtD
Omeprazole—Somnolence—Methotrexate—ankylosing spondylitis	4.73e-05	0.000716	CcSEcCtD
Omeprazole—Hypersensitivity—Prednisone—ankylosing spondylitis	4.69e-05	0.00071	CcSEcCtD
Omeprazole—Dyspepsia—Methotrexate—ankylosing spondylitis	4.68e-05	0.000709	CcSEcCtD
Omeprazole—Vomiting—Dexamethasone—ankylosing spondylitis	4.65e-05	0.000704	CcSEcCtD
Omeprazole—Vomiting—Betamethasone—ankylosing spondylitis	4.65e-05	0.000704	CcSEcCtD
Omeprazole—Decreased appetite—Methotrexate—ankylosing spondylitis	4.62e-05	0.0007	CcSEcCtD
Omeprazole—Rash—Betamethasone—ankylosing spondylitis	4.61e-05	0.000698	CcSEcCtD
Omeprazole—Rash—Dexamethasone—ankylosing spondylitis	4.61e-05	0.000698	CcSEcCtD
Omeprazole—Dermatitis—Dexamethasone—ankylosing spondylitis	4.6e-05	0.000697	CcSEcCtD
Omeprazole—Dermatitis—Betamethasone—ankylosing spondylitis	4.6e-05	0.000697	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	4.59e-05	0.000695	CcSEcCtD
Omeprazole—Fatigue—Methotrexate—ankylosing spondylitis	4.59e-05	0.000694	CcSEcCtD
Omeprazole—Headache—Dexamethasone—ankylosing spondylitis	4.58e-05	0.000693	CcSEcCtD
Omeprazole—Headache—Betamethasone—ankylosing spondylitis	4.58e-05	0.000693	CcSEcCtD
Omeprazole—Asthenia—Prednisone—ankylosing spondylitis	4.57e-05	0.000691	CcSEcCtD
Omeprazole—Pain—Methotrexate—ankylosing spondylitis	4.55e-05	0.000689	CcSEcCtD
Omeprazole—Pruritus—Prednisone—ankylosing spondylitis	4.5e-05	0.000682	CcSEcCtD
Omeprazole—Feeling abnormal—Methotrexate—ankylosing spondylitis	4.38e-05	0.000664	CcSEcCtD
Omeprazole—Diarrhoea—Prednisone—ankylosing spondylitis	4.35e-05	0.000659	CcSEcCtD
Omeprazole—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	4.35e-05	0.000659	CcSEcCtD
Omeprazole—Nausea—Betamethasone—ankylosing spondylitis	4.34e-05	0.000657	CcSEcCtD
Omeprazole—Nausea—Dexamethasone—ankylosing spondylitis	4.34e-05	0.000657	CcSEcCtD
Omeprazole—Urticaria—Methotrexate—ankylosing spondylitis	4.23e-05	0.00064	CcSEcCtD
Omeprazole—Dizziness—Prednisone—ankylosing spondylitis	4.21e-05	0.000637	CcSEcCtD
Omeprazole—Abdominal pain—Methotrexate—ankylosing spondylitis	4.21e-05	0.000637	CcSEcCtD
Omeprazole—Body temperature increased—Methotrexate—ankylosing spondylitis	4.21e-05	0.000637	CcSEcCtD
Omeprazole—Vomiting—Prednisone—ankylosing spondylitis	4.05e-05	0.000613	CcSEcCtD
Omeprazole—Rash—Prednisone—ankylosing spondylitis	4.01e-05	0.000608	CcSEcCtD
Omeprazole—Dermatitis—Prednisone—ankylosing spondylitis	4.01e-05	0.000607	CcSEcCtD
Omeprazole—Headache—Prednisone—ankylosing spondylitis	3.99e-05	0.000604	CcSEcCtD
Omeprazole—Hypersensitivity—Methotrexate—ankylosing spondylitis	3.92e-05	0.000593	CcSEcCtD
Omeprazole—Asthenia—Methotrexate—ankylosing spondylitis	3.82e-05	0.000578	CcSEcCtD
Omeprazole—Nausea—Prednisone—ankylosing spondylitis	3.78e-05	0.000572	CcSEcCtD
Omeprazole—Pruritus—Methotrexate—ankylosing spondylitis	3.76e-05	0.00057	CcSEcCtD
Omeprazole—Diarrhoea—Methotrexate—ankylosing spondylitis	3.64e-05	0.000551	CcSEcCtD
Omeprazole—Dizziness—Methotrexate—ankylosing spondylitis	3.52e-05	0.000533	CcSEcCtD
Omeprazole—Vomiting—Methotrexate—ankylosing spondylitis	3.38e-05	0.000512	CcSEcCtD
Omeprazole—Rash—Methotrexate—ankylosing spondylitis	3.35e-05	0.000508	CcSEcCtD
Omeprazole—Dermatitis—Methotrexate—ankylosing spondylitis	3.35e-05	0.000507	CcSEcCtD
Omeprazole—Headache—Methotrexate—ankylosing spondylitis	3.33e-05	0.000505	CcSEcCtD
Omeprazole—Nausea—Methotrexate—ankylosing spondylitis	3.16e-05	0.000478	CcSEcCtD
